Reneo Pharmaceuticals, Inc. (RPHM)
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
$50.48M
Mr. Gregory J. Flesher
32.00
Irvine, CA
Apr 09, 2021
-0.90
$-1.68
0.66
10.65
0.00%
-3.07
-0.06
1.35
0.00
10.39
-39.47%
-54.15%
Similar stocks (20)
Summit Therapeutics Inc.
SMMT
Royalty Pharma plc
RPRX
Legend Biotech Corporation
LEGN
Apellis Pharmaceuticals, Inc.
APLS
Edgewise Therapeutics, Inc.
EWTX
Vir Biotechnology, Inc.
VIR
Cullinan Oncology, Inc.
CGEM
Adaptive Biotechnologies Corporation
ADPT
Celcuity Inc.
CELC
Prime Medicine, Inc.
PRME
Ginkgo Bioworks Holdings, Inc.
DNA
C4 Therapeutics, Inc.
CCCC
Nkarta, Inc.
NKTX
Werewolf Therapeutics, Inc.
HOWL
Kronos Bio, Inc.
KRON
Immix Biopharma, Inc.
IMMX
Kezar Life Sciences, Inc.
KZR
Ocean Biomedical, Inc.
OCEA
CNS Pharmaceuticals, Inc.
CNSP
Hepion Pharmaceuticals, Inc.
HEPA
ETF Exposure (9)
iShares Micro-Cap ETF
IWC
0.00765%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.005%
iShares Biotechnology ETF
IBB
0.00277%
ProShares Ultra Nasdaq Biotechnology
BIB
0.0013786187817880872%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (20)
Summit Therapeutics Inc.
SMMT
Royalty Pharma plc
RPRX
Legend Biotech Corporation
LEGN
Apellis Pharmaceuticals, Inc.
APLS
Edgewise Therapeutics, Inc.
EWTX
Vir Biotechnology, Inc.
VIR
Cullinan Oncology, Inc.
CGEM
Adaptive Biotechnologies Corporation
ADPT
Celcuity Inc.
CELC
Prime Medicine, Inc.
PRME
Ginkgo Bioworks Holdings, Inc.
DNA
C4 Therapeutics, Inc.
CCCC
Nkarta, Inc.
NKTX
Werewolf Therapeutics, Inc.
HOWL
Kronos Bio, Inc.
KRON
Immix Biopharma, Inc.
IMMX
Kezar Life Sciences, Inc.
KZR
Ocean Biomedical, Inc.
OCEA
CNS Pharmaceuticals, Inc.
CNSP
Hepion Pharmaceuticals, Inc.
HEPA
ETF Exposure (9)
iShares Micro-Cap ETF
IWC
0.00765%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.005%
iShares Biotechnology ETF
IBB
0.00277%
ProShares Ultra Nasdaq Biotechnology
BIB
0.0013786187817880872%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%